TUGAS KELAS XII TP 2 SMK KB PUSDIKPAL

v>

LEMBAR KERJA SISWA (LKS)

PEMBELAJARAN VIRUS CORONA ( COVID-19)

PETUNUJUK PENGISIAN LKS : 

1. Cermatilah berbagai informasi tentang Virus dan Virus Corona dari

berbagai sumber baik yang diberikan oleh guru atau berasal dari

sumber lain yang dapat siswa akses dari berbagai mas media.

2. Materi pada LKS ini hanya merupakan salah satu sumber belajar

alternatif

3. Isilah/lakukan tugas yang diberikan dalam LKS dengan lengkap

4. Untuk tugas berupa produk rancangan, dikumpulkan pada saat

Proses Pembelajaran melalui tatap muka mulai aktif kembali

(produk difoto terlebih dahulu dan dikirim melalui media sosial

yang dapat terhubung dengan wali kelas masing-masing )

5. Tugas diserahkan paling lambat tanggal 21 Maret 2020

MATERI :

INTERNATIONAL PROTOCOL TO RESPONSE COVID-19

(Sumber : World Health Organization)

The Global Response & Next Steps

1. The COVID-19 virus is a new pathogen that is highly contagious, can

spread quickly, and must be considered capable of causing enormous

health, economic and societal impacts in any setting. It is not SARS

and it is not influenza. Building scenarios and strategies only on the

basis of well-known pathogens risks failing to exploit all possible measures to slow transmission of the COVID-19 virus, reduce disease

and save lives.

COVID-19 is not SARS and it is not influenza. It is a new virus with its

own characteristics. For example, COVID-19 transmission in children

appears to be limited compared with influenza, while the clinical

picture differs from SARS. Such differences, while based on limited

data, may be playing a role in the apparent efficacy of rigorously 19

applied non-pharmaceutical, public health measures to interrupt

chains of human-tohuman transmission in a range of settings in

China. The COVID-19 virus is unique among human coronaviruses in

its combination of high transmissibility, substantial fatal outcomes in

some high-risk groups, and ability to cause huge societal and

economic disruption. For planning purposes, it must be assumed that

the global population is susceptible to this virus. As the animal origin

of the COVID-19 virus is unknown at present, the risk of

reintroduction into previously infected areas must be constantly

considered. The novel nature, and our continuously evolving

understanding, of this coronavirus demands a tremendous agility in

our capacity to rapidly adapt and change our readiness and response

planning as has been done continually in China. This is an

extraordinary feat for a country of 1.4 billion people.

2. China’s uncompromising and rigorous use of non-pharmaceutical

measures to contain transmission of the COVID-19 virus in multiple

settings provides vital lessons for the global response. This rather

unique and unprecedented public health response in China reversed

the escalating cases in both Hubei, where there has been widespread community transmission, and in the importation provinces, where

family clusters appear to have driven the outbreak.

Although the timing of the outbreak in China has been relatively

similar across the country, transmission chains were established in a

wide diversity of settings, from megacities in the north and south of

the country, to remote communities. However, the rapid adaptation

and tailoring of China’s strategy demonstrated that containment can

be adapted and successfully operationalized in a wide range of

settings. China’s experience strongly supports the efficacy and

effectiveness of anchoring COVID19 readiness and rapid response

plans in a thorough assessment of local risks and of utilizing a

differentiated risk-based containment strategy to manage the

outbreak in areas with no cases vs. sporadic cases vs. clusters of

cases vs. community-level transmission. Such a strategy is essential

for ensuring a sustainable approach while minimizing the socio

economic impact.

3. Much of the global community is not yet ready, in mindset and

materially, to implement the measures that have been employed to

contain COVID-19 in China. These are the only measures that are

currently proven to interrupt or minimize transmission chains in

humans. Fundamental to these measures is extremely proactive

surveillance to immediately detect cases, very rapid diagnosis and

immediate case isolation, rigorous tracking and quarantine of close

contacts, and an exceptionally high degree of population

understanding and acceptance of these measures. Achieving the high quality of implementation needed to be successful

with such measures requires an unusual and unprecedented speed

of decision-making by top leaders, operational thoroughness by

public health systems, and engagement of society. 20 Given the

damage that can be caused by uncontrolled, community-level

transmission of this virus, such an approach is warranted to save lives

and to gain the weeks and months needed for the testing of

therapeutics and vaccine development. Furthermore, as the majority

of new cases outside of China are currently occurring in high and

middleincome countries, a rigorous commitment to slowing

transmission in such settings with non-pharmaceutical measures is

vital to achieving a second line of defense to protect low income

countries that have weaker health systems and coping capacities. The

time that can be gained through the full application of these

measures – even if just days or weeks – can be invaluable in

ultimately reducing COVID-19 illness and deaths. This is apparent in

the huge increase in knowledge, approaches and even tools that has

taken place in just the 7 weeks since this virus was discovered

through the rapid scientific work that has been done in China.

4. The time gained by rigorously applying COVID-19 containment

measures must be used more effectively to urgently enhance global

readiness and rapidly develop the specific tools that are needed to

ultimately stop this virus.

COVID-19 is spreading with astonishing speed; COVID-19 outbreaks

in any setting have very serious consequences; and there is now

strong evidence that non-pharmaceutical interventions can reduce

and even interrupt transmission. Concerningly, global and national preparedness planning is often ambivalent about such interventions.

However, to reduce COVID-19 illness and death, near-term readiness

planning must embrace the large-scale implementation of high

quality, non-pharmaceutical public health measures. These measures

must fully incorporate immediate case detection and isolation,

rigorous close contact tracing and monitoring/quarantine, and direct

population/community engagement. A huge array of COVID-19

studies, scientific research projects and product R&D efforts are

ongoing in China and globally. This is essential and to be encouraged

and supported. However, such a large number of projects and

products needs to be prioritized. Without prioritizing, this risks

compromising the concentration of attention and resources and

collaboration required to cut timelines by precious weeks and

months. While progress has been made, the urgency of the COVID-

19 situation supports an even more ruthless prioritization of research

in the areas of diagnostics, therapeutics and vaccines. Similarly, there

is a long list of proposed studies on the origins of COVID-19, the

natural history of the disease, and the virus’s transmission dynamics.

However, the urgency of responding to cases and saving lives makes

it difficult for policy makers to consider and act on such

comprehensive lists. This can be addressed by balancing studies with

the immediate public health and clinical needs of the response.

Studies can be prioritized in terms of the largest knowledge gaps that

can be most rapidly addressed to have greatest immediate impact on

response operations and patient management. This suggests

prioritizing studies to identify risk factors for transmission in

households, institutions and the community; convenience sampling

for this virus in the population using existing surveillance systems;

age-stratified sero-epidemiologic surveys; the analysis of clinical case

series; and cluster investigations.For countries with imported cases and/or outbreaks of COVID-19

1. Immediately activate the highest level of national Response

Management protocols to ensure the all-of-government and all-of

society approach needed to contain COVID-19 with non

pharmaceutical public health measures;

2. Prioritize active, exhaustive case finding and immediate testing and

isolation, painstaking contact tracing and rigorous quarantine of

close contacts;

3. Fully educate the general public on the seriousness of COVID-19 and

their role in preventing its spread;

4. Immediately expand surveillance to detect COVID-19 transmission

chains, by testing all patients with atypical pneumonias, conducting

screening in some patients with upper respiratory illnesses and/or

recent COVID-19 exposure, and adding testing for the COVID-19 virus

to existing surveillance systems (e.g. systems for influenza-like-illness

and SARI); and 22

5. Conduct multi-sector scenario planning and simulations for the

deployment of even more stringent measures to interrupt

transmission chains as needed (e.g. the suspension of large-scale

gatherings and the closure of schools and workplaces).

For uninfected countries

1. Prepare to immediately activate the highest level of emergency

response mechanisms to trigger the all-of-government and all-of

society approach that is essential for early containment of a COVID-

19 outbreak;

2. Rapidly test national preparedness plans in light of new knowledge

on the effectiveness of non-pharmaceutical measures against COVID-19; incorporate rapid detection, largescale case isolation and

respiratory support capacities, and rigorous contact tracing and

management in national COVID-19 readiness and response plans

and capacities;

3. Immediately enhance surveillance for COVID-19 as rapid detection is

crucial to containing spread; consider testing all patients with

atypical pneumonia for the COVID-19 virus, and adding testing for

the virus to existing influenza surveillance systems;

4. Begin now to enforce rigorous application of infection prevention

and control measures in all healthcare facilities, especially in

emergency departments and outpatient clinics, as this is where

COVID-19 will enter the health system; and

5. Rapidly assess the general population’s understanding of COVID-19,

adjust national health promotion materials and activities accordingly,

and engage clinical champions to communicate with the media.

For the public

1. Recognize that COVID-19 is a new and concerning disease, but that

outbreaks can managed with the right response and that the vast

majority of infected people will recover;

2. Begin now to adopt and rigorously practice the most important

preventive measures for COVID-19 by frequent hand washing and

always covering your mouth and nose when sneezing or coughing;

3.Continually update yourself on COVID-19 and its signs and symptoms

(i.e. fever and dry cough), because the strategies and response

activities will constantly improve as new information on this disease

is accumulating every day; and 4. Be prepared to actively support a response to COVID-19 in a variety

of ways, including the adoption of more stringent ‘social distancing’

practices and helping the high-risk elderly population. 23

For the international community

1. Recognize that true solidarity and collaboration is essential between

nations to tackle the common threat that COVID-19 represents and

operationalize this principle;

2. Rapidly share information as required under the International Health

Regulations (IHR) including detailed information about imported

cases to facilitate contact tracing and inform containment measures

that span countries;

3. Recognize the rapidly changing risk profile of COVID-19 affected

countries and continually monitor outbreak trends and control

capacities to reassess any ‘additional health measures’ that

significantly interfere with international travel and trade.

KEGIATAN PEMBELAJARAN :

1. Terjemahkanlah, cermati dan pahami artikel berjudul

INTERNATIONAL PROTOCOL TO RESPONSE COVID-19 untuk

memahami virus Corona.

2. Carilah berbagai sumber belajar tentang Virus Corona, dapat

bersumber dari guru atau hasil browsing oleh siswa sendiri.

3. Virus memiliki beberapa jenis, secara umum memiliki karakteristik,

klasifikasi dan penyakit-penyakit yang dapat disebabkannya yang

khas . Analisislah karakteristik virus berdasarkan :

a. Ciri-ciri virus

………………………………………………………………………………………….………………………………………………………………………………………….

…………………………………………………………………………………………

b. Bentuk virus

………………………………………………………………………………………….

………………………………………………………………………………………….

…………………………………………………………………………………………

c. Struktur virus

………………………………………………………………………………………….

………………………………………………………………………………………….

…………………………………………………………………………………………

d. Cara hidup virus

………………………………………………………………………………………….

………………………………………………………………………………………….

…………………………………………………………………………………………

e. Perkembangbiakan virus

………………………………………………………………………………………….

………………………………………………………………………………………….

…………………………………………………………………………………………

f. Klasifikasi Virus

………………………………………………………………………………………….

………………………………………………………………………………………….…………………………………………………………………………………………

g. Penyakit yang disebabkan virus

………………………………………………………………………………………….

………………………………………………………………………………………….

…………………………………………………………………………………………

4. Virus Corona merupakan satu jenis virus yang dapat menyebabkan

penyakit dan sedang mewabah. Evaluasilah berdasarkan berbagai

sumber belajar terkait dengan :

a. -Latar Belakang mewabahnya virus corona,

…………………………………………………………………………………………..

…………………………………………………………………………………………..

……………………………………………………………………………………….….

b. gejala terinfeksi virus corona,

………………………………………………………………………………………….

………………………………………………………………………………………….

………………………………………………………………….………………………

c. cara penyebaran Virus Corona,

………………………………………………………………………………………….

………………………………………………………………………………………….

…………………………………………………………………………………………

d. pencegahan terhadap terjangkitnya Virus Corona

………………………………………………………………………………………….

………………………………………………………………………………………….

…………………………………………………………………………………………

e. Cara penanganan5. Setelah memcermati dan mempelajari materi “ Protokol

Penanganan Virus Corona “ dari materi alternative atau sumber

lain,

a.Rancanglah media informasi sederhana tentang tahapan

menerapkan protokol penanganan virus Corona dalam media

tertulis. (Dikerjakan dalam lembar Terpisah).

b. Bagaimana harus menanggapi secara bijak saat ada stigma di

masyarakat tentang virus corona ?

…………………………………………………………………………………………………..

…………………………………………………………………………………………………..

……………………………………………………………………………………..……………

6. Setelah mencermati dan mempelajari materi tentang Cara Hidup

Sehat, rancanglah media informasi sederhana tentang bagaimana

mengimplementasikan cara hidup sehat. (Dikerjakan dalam lembar

terpisah). Materia media informasi memuat :

a. Menjaga kebersihan diri

b. Menjaga kebersihan lingkungan sekitar

c. Cara menjaga kesehatan

d. Olahraga yang aman dan sehat

7. Setelah mencermati dan mempelajari tentang virus Corona dan

merebaknya informasi di berbagai media yang belum tentu

kejelasannya atau kebenarannya. Jika menjadi Agen Informasi

Covid-19, Jelaskan bagaimana cara bersosialisasi yang bijak di

masyarakat agar tindakan dan informasi yang disampaikan saat

bersosialisasi membantu pencegahan menyebarnya wabah

penyakit yang disebabkan virus Corona ?

………………………………………………………………………………………….

………………………………………………………………………………………….

…………………………………………………………………………………………………………………………………………………………………………………….

………………………………………………………………………………………….

…………………………………………………………………………